Ba Duong Nguyen MD, Presenter: Nothing to Disclose

Panol Chir Ram MD, Abstract Co-Author: Nothing to Disclose

Michael C. Roarke MD, Abstract Co-Author: Nothing to Disclose

Through the exhibit, the viewers (1) learn the impact of PET/CT in the diagnosis, staging and re-staging of different gynecologic malignancies, (2) understand the applications, limitations and pitfalls of PET/CT in gynecologic oncology, and (3) know how to contribute to the optimized care of gynecologic patients.

The authors present a pictorial essay on F-18 FDG PET/CT evaluation of cancer of the uterus, ovary, cervix, vagina, and vulva along with other less common types of neoplasias targeting these organs. Advantages of PET/CT imaging over other types of conventional radiologic imaging modalities are discussed and illustrated at different stages of the gynecologic diseases.

Gynecologic neoplasms represent one of the major medical challenges for diagnosis, staging, treatment and post-therapeutic surveillance. With the advent of laparoscopic/ robotic surgery and large accessible armamentarium of chemoradiation therapeutic options, PET/CT functional imaging provides a significant impact in patient care for different types of gynecologic malignancies. This clinical impact is presented in this exhibit.

Nguyen, B, Ram, P, Roarke, M, F-18 FDG PET/CT Imaging in Gynecologic Oncology: Pictorial Essay.  Radiological Society of North America 2010 Scientific Assembly and Annual Meeting, November 28 - December 3, 2010 ,Chicago IL. http://archive.rsna.org/2010/9003107.html